These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22870114)

  • 1. ERα and ERβ expression in correlation with Ki-67, Bcl-2 and Bak in primary tumors and lymph node metastases of breast cancer: The effect of pre-operative chemotherapy.
    Kanczuga-Koda L; Koda M; Tomaszewski J; Jarzabek K; Lotowska J; Baltaziak M; Sulkowska U; Sobaniec-Lotowska M; Sulkowski S
    Oncol Lett; 2010 Nov; 1(6):1067-1071. PubMed ID: 22870114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.
    Koda M; Sulkowska M; Kanczuga-Koda L; Tomaszewski J; Kucharczuk W; Lesniewicz T; Cymek S; Sulkowski S
    Oncol Rep; 2007 Jul; 18(1):113-9. PubMed ID: 17549355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.
    Koda M; Lenczewski A; Sulkowska M; Kanczuga-Koda L; Wincewicz A; Tomaszewski J; Sulkowski S
    Oncol Rep; 2007 Feb; 17(2):385-91. PubMed ID: 17203178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer.
    Koda M; Sulkowski S; Kanczuga-Koda L; Surmacz E; Sulkowska M
    Oncol Rep; 2004 Apr; 11(4):753-9. PubMed ID: 15010868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases.
    Koda M; Sulkowska M; Kanczuga-Koda L; Sulkowski S
    J Clin Pathol; 2005 Jun; 58(6):645-9. PubMed ID: 15917419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
    J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
    Bozkurt KK; Kapucuoğlu N
    Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta.
    Koda M; Sulkowski S; Garofalo C; Kanczuga-Koda L; Sulkowska M; Surmacz E
    Horm Metab Res; 2003; 35(11-12):794-801. PubMed ID: 14710360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki-67 expression in axillary lymph node metastases in breast cancer is prognostically significant.
    Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
    Hum Pathol; 2013 Jan; 44(1):39-46. PubMed ID: 22939959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.
    Bièche I; Parfait B; Laurendeau I; Girault I; Vidaud M; Lidereau R
    Oncogene; 2001 Dec; 20(56):8109-15. PubMed ID: 11781824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of keratinocyte growth factor and its receptor in human breast cancer: its inhibitory role in the induction of apoptosis possibly through the overexpression of Bcl-2.
    Hishikawa Y; Tamaru N; Ejima K; Hayashi T; Koji T
    Arch Histol Cytol; 2004 Dec; 67(5):455-64. PubMed ID: 15781986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision.
    Georgescu R; Boros M; Moncea D; Bauer O; Coros MF; Oprea A; Moldovan C; Podoleanu C; Stolnicu S
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):533-538. PubMed ID: 28099174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of estrogen receptor and Ki-67 index after neoadjuvant chemotherapy in locally advanced breast cancer expressing high levels of proliferation at diagnosis.
    Miglietta L; Vanella P; Canobbio L; Naso C; Cerisola N; Meszaros P; Parodi MA; Morabito F
    Oncology; 2010; 79(3-4):255-61. PubMed ID: 21372600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.
    Järvinen TA; Pelto-Huikko M; Holli K; Isola J
    Am J Pathol; 2000 Jan; 156(1):29-35. PubMed ID: 10623650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer.
    Sierra A; Castellsagué X; Escobedo A; Lloveras B; García-Ramirez M; Moreno A; Fabra A
    Int J Cancer; 2000 Mar; 89(2):142-7. PubMed ID: 10754491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptors and proliferation markers in primary and recurrent breast cancer.
    Jensen EV; Cheng G; Palmieri C; Saji S; Mäkelä S; Van Noorden S; Wahlström T; Warner M; Coombes RC; Gustafsson JA
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15197-202. PubMed ID: 11734621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of Estrogen Receptor β Isoform With Correlation of Estrogen Receptor α Among Sudanese Breast Cancer Patients.
    Shalabi MG; Abbas AM; Mills J; Kheirelseid MA; Elderdery AY
    Breast Cancer (Auckl); 2021; 15():1178223421998354. PubMed ID: 33716507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.